The U.S. pharmaceutical packaging market is projected to grow significantly from USD 52.48 billion in 2025 to USD 99.44 billion by 2034, at a CAGR of 7.36% during 2025–2034. Driven by rising drug production, demand for personalized medicine and biologics, strict regulatory standards, and innovations in sustainable, smart, and tamper-evident packaging, the market is entering a dynamic growth phase.
This article explores the market size, demand, trends, and profiles of key companies shaping the U.S. pharmaceutical packaging landscape.
2025 Market Size: USD 52.48 billion
2034 Market Size: USD 99.44 billion
CAGR (2025–2034): 7.36%
Increasing production of biologics and personalized medicine.
Adoption of sustainable and eco-friendly packaging solutions.
Regulatory push for tamper-evident and smart packaging.
Primary packaging dominates and remains vital for product safety.
Syringes & cartridges are projected to see significant growth.
Plastic materials lead, while biodegradable films gain traction.
Oral drug delivery holds the major market share.
About: Amcor is a global leader in responsible packaging solutions serving the pharmaceutical, healthcare, and consumer goods sectors.
Products: Offers flexible packaging, rigid containers, specialty cartons, closures, and services focusing on sustainability.
Market Cap: Approx. USD 15 billion.
About: A German company with strong U.S. operations, Gerresheimer provides glass and plastic packaging for the pharmaceutical industry.
Products: Known for glass vials, ampoules, syringes, and plastic containers for drug delivery systems.
Market Cap: Around USD 3.6 billion.
About: West is a leading provider of innovative solutions for injectable drug administration.
Products: Specializes in elastomer, metal, and plastic components, and delivery systems such as syringes and cartridges.
Market Cap: Approximately USD 20 billion.
Invest in Our Premium Strategic Solution: https://www.towardspackaging.com/price/5701
About: A German multinational with a significant U.S. footprint, Schott is renowned for high-tech materials and components.
Products: Pharmaceutical glass packaging, syringes, ampoules, and vials made from borosilicate glass.
Market Cap: Private company (subsidiary of Carl Zeiss Foundation).
About: Aptar is a global leader in dispensing systems for pharmaceutical, beauty, and food markets.
Products: Provides drug delivery devices such as nasal sprays, pumps, and inhalers.
Market Cap: Around USD 8 billion.
About: Berry Global provides innovative packaging solutions with a focus on sustainability.
Products: Offers plastic pharmaceutical packaging, including bottles, closures, and films.
Market Cap: Approximately USD 7 billion.
About: Catalent is a U.S.-based leader in drug delivery technologies and manufacturing solutions.
Products: Offers primary packaging services, including prefilled syringes and blister packaging.
Market Cap: Around USD 8.5 billion.
About: BD is a leading global medical technology company with a strong focus on injectable drug delivery systems.
Products: Prefilled syringes, drug delivery systems, and sterile packaging solutions.
Market Cap: Approx. USD 75 billion.
About: Nipro is a Japanese company with U.S. operations, focusing on medical and pharmaceutical packaging solutions.
Products: Prefilled syringes, glass ampoules, and rubber closures.
Market Cap: Approx. USD 2.5 billion.
About: SGD Pharma is a leading glass packaging manufacturer for pharmaceutical products.
Products: Specializes in molded and tubular glass vials and bottles.
Market Cap: Private company.
About: O-I Glass is a global leader in glass container manufacturing.
Products: Produces glass packaging solutions for pharmaceutical and healthcare industries.
Market Cap: Around USD 3 billion.
About: WestRock provides paper and packaging solutions for diverse industries, including healthcare.
Products: Cartons, folding boxes, and specialty packaging for pharmaceuticals.
Market Cap: Approx. USD 9 billion.
About: Sonoco offers diversified packaging solutions, including sustainable options.
Products: Rigid paper containers, flexible packaging, and temperature-assured packaging for drugs.
Market Cap: Around USD 6 billion.
About: Comar provides innovative packaging and dispensing solutions for healthcare markets.
Products: Plastic bottles, closures, and dispensing systems.
Market Cap: Private company.
About: SiO2 develops advanced hybrid packaging materials for pharmaceuticals and biologics.
Products: Vials, syringes, and drug delivery systems made from a unique glass-plastic composite.
Market Cap: Private company.
About: Alpla is a global leader in plastic packaging solutions with a focus on sustainability.
Products: Bottles, closures, and innovative plastic packaging for pharmaceuticals.
Market Cap: Private company.
Request a personalized case study designed around your business goals and gain strategic
insights into the global packaging industry. Connect with us at: sales@towardspackaging.com
The growth is fueled by rising drug production, demand for biologics, eco-friendly packaging innovations, and regulatory emphasis on tamper-evident and smart packaging solutions.
The primary packaging segment dominates due to its critical role in ensuring drug safety and quality.
Plastic holds the largest market share, but biodegradable and polymer films are gaining momentum due to sustainability concerns.
Major players include Amcor plc, Gerresheimer AG, West Pharmaceutical Services, Inc., Schott AG, and AptarGroup, Inc.
The market is projected to reach USD 99.44 billion by 2034, growing at a CAGR of 7.36%.
Source : https://www.towardspackaging.com/insights/us-pharmaceutical-packaging-market-sizing
The North America plastic packaging market is undergoing a remarkable transformation, fueled by rapid technological…
The U.S. pharmaceutical packaging market is undergoing a dynamic transformation, fueled by a potent mix…
From sleek glass bottles to smart AI-driven production lines, the U.S. cosmetic packaging market is…
Germany is rewriting the rulebook for packaging and it’s flexing more than just its economic…
A Rapidly Expanding Market, Valued at Over $14 Billion by 2034 Canada's pharmaceutical packaging sector…
Europe consumer packaged goods (CPG) sector is on the verge of a transformation. Forecasts signal…